医学
冠状动脉疾病
内科学
病变
急性冠脉综合征
心脏病学
脂肪组织
靶病变
炎症
狭窄
心肌梗塞
病理
经皮冠状动脉介入治疗
作者
Jeremy Yuvaraj,Andrew Lin,Nitesh Nerlekar,Ravi Kiran Munnur,James N. Cameron,Stephen J. Nicholls,D. Wong
标识
DOI:10.1093/ehjci/ehaa946.1571
摘要
Abstract Background High-risk plaque (HRP) features detected on computed tomography coronary angiography (CTCA) are associated with subsequent development of acute coronary syndrome (ACS). Pericoronary adipose tissue attenuation (PCAT) is a novel CT-derived non-invasive marker of coronary inflammation. The association between PCAT, HRP and outcomes is unknown. Purpose To evaluate the association between high-risk plaque HRP characteristics, ACS and PCAT attenuation as a surrogate marker of coronary inflammation. Methods Patients with stable chest pain referred for CTCA between 2011 and 2013 with outcome data were included. Patients with HRP were propensity matched to patients without HRP. PCAT-RCA and PCAT-lesion were assessed using semi-automated software (AutoPlaque version 2.0). PCAT-RCA was measured around the proximal 10–50 mm of the right coronary artery (RCA). PCAT-lesion was measured around the HRP or lesion with highest-grade stenosis in patients without HRP. Results 78 patients (67±10 years, 67% males) included 41 (52.6%) patients with HRP. Median PCAT-RCA was higher in HRP patients than non-HRP patients (−80.4 HU [IQR −86.1, −76.5] vs. −86.3 HU [IQR −92.2, −77.0], p=0.02). PCAT-Lesion was not significantly different between HRP and non-HRP patients (−78.7 HU [IQR −84.4, −73.4] vs. −82.8 HU [IQR −91.1, −75.4], p=0.16). More patients with HRP developed a subsequent ACS (24.4% vs. 5.4%, p=0.008). HRP patients who experienced an ACS demonstrated a higher PCAT-RCA (−76.6 HU [IQR −81.3, −72.4] vs. −82.6 HU [IQR −87.4, −78.0], p=0.018) and PCAT-lesion (−74.3 HU [IQR −77.1, −68.4] vs. −80.7 HU [IQR −84.8, −74.9], p=0.04) compared to those who did not experience an ACS. Conclusion PCAT attenuation is elevated in stable CAD patients with HRP features. Measures of periarterial inflammation were also more evident in HRP patients who develop ACS, indicating a potential contribution to vulnerability. The implications for integration of these measures in clinical practice require further investigation. Funding Acknowledgement Type of funding source: None
科研通智能强力驱动
Strongly Powered by AbleSci AI